Pharmaceutical Stocks Recent News
The Street Is Misreading Sarepta's Guidance
Risks Remain For Alexion Even As Early Internal Investigation Results Seem Positive
Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals
Last Night's Election - A Series Of Fortunate Events For Big Pharma
Valeant's Salix Story: To Sell Or Not To Sell?
Benzinga Talks With Imprimis Pharmaceuticals' CEO About Earnings, MKO Melt, Drug Pricing And More
AbbVie Shares Trading At A Discount To Other Pharmaceuticals; Argus Reaffirms With A Buy Rating
Importance Of Phase 1 Trials
Acorda Dips 2%, Company Says It Will Discontinue Development Of Nasal Spray
Regeneron Gains 4% Following Q1 Earnings Release
B. Riley Cuts Perrigo's Price Target From $146 To $113 On Papa's Exit, FY16 Guidance
Pharma Names Under Pressure Amid Perrigo Warning
Allergan Announces Acquisition Of Topokine Therapeutics, Highlights Fat Reduction Development Program
Kite Pharma Gains 2% After Management Provides Update To A Phase 1 Study
This Explains Horizon Pharma's 25% Plunge
Biogen's Stock Pops Following Better-Than-Expected Q4 Results
Relypsa Up 10% Following Encouraging Phase 1 Study Results
Shares Of Catabasis Pharmaceuticals See-Saw Following Results Of Duchenne Muscular Dystrophy Study
Agile Therapeutics Plunges After Company Prices A Stock Offering At $6.35 Per Share
Vetr Top Raters Upgrade Mannkind To 4.5-Star Stock
These Three Pharma Giants Just Crushed Earnings
Bristol-Myers and Quidel to Open Near 52-Week Highs
Perrigo Earnings Preview